The Molecular Analysis for Precision Oncology (MAP) Congress 2026, co-organized by the European Society for Medical Oncology (ESMO), Cancer Research UK (CRUK), and Unicancer, is scheduled for 10–11 September 2026 in London, United Kingdom.

This high-level, two-day meeting will serve as a platform for experts in oncology, molecular diagnostics, and precision medicine to converge and exchange ideas.

The primary focus of the congress is to share advances in cancer research, strengthen interdisciplinary connections, and accelerate the translation of molecular insights – particularly concerning molecular profiling, biomarker discovery, and personalized treatment strategies – into routine clinical practice to improve global patient care.